Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:DENV-1
gptkb:DENV-2 gptkb:DENV-3 |
| gptkbp:approves |
gptkb:Indonesia
gptkb:Brazil |
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:developed_by |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:effective_date |
gptkb:2022
|
| https://www.w3.org/2000/01/rdf-schema#label |
Qdenga
|
| gptkbp:is_effective_against |
approximately 80%
|
| gptkbp:manager |
subcutaneous
|
| gptkbp:targets |
gptkb:Dengue_fever
|
| gptkbp:type |
dengue vaccine
|